Catheter Precision, Inc. is a medical device company. It is engaged in providing new solutions to the market to improve the treatment of cardiac arrhythmias. It is focused on developing technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products. It is also focused on developing and delivering electrophysiology products to provide patients, hospitals, and physicians with novel technologies and solutions to improve the lives of patients with cardiac arrhythmias. Its product is the VIVO System, which is an anacronym for View into Ventricular Onset System, which is a non-invasive imaging system that offers three-dimensional cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients. Its LockeT product is a suture retention device indicated for wound healing. Its product portfolio also includes the Amigo Remote Catheter System, a robotic arm that serves as a catheter control device.
Ticker SymbolVTAK
Company nameCatheter Precision Inc
IPO dateSep 27, 2018
CEOMr. David Jenkins
Number of employees22
Security typeOrdinary Share
Fiscal year-endSep 27
Address1670 Highway 160 West
CityFORT MILL
Stock exchangeNYSE American Consolidated
CountryUnited States of America
Postal code29708
Phone19736912000
Websitehttps://www.ramed.com/
Ticker SymbolVTAK
IPO dateSep 27, 2018
CEOMr. David Jenkins
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data